Navigation Links
Taq DNA Polymerase -Klein Taq from AppliChem GmbH

ProductsTaq DNA Polymerase -Klein Taq from AppliChem GmbH
Company AppliChem GmbH
Item Taq DNA Polymerase -Klein Taq
Price 
Description Klein Taq is a derivative of Taq DNA polymerase. It is a 5'-exo-minus N-terminally truncated Thermus aquaticus DNA polymerase. Expressed from a gene construct in E. coli, translation initiates at Met236, bypassing the 5'-3' exonuclease domain of the DNA polymerase-encoding gene. The enzyme reveals a highly active and even more heat-stable DNA polymerase activity in comparison with Taq DNA polymerase. The optimal range of the Mg2+ concentration for Klein Taq is broader than that for the majority of thermostable polymerases. This feature permits to optimize reaction conditions easier than for other polymerases. Repeated exposure to 98 C does not diminish the enzyme activity. Significant activity remains even after exposure to 99 C.

The mutation rate during polymerization is twofold lower for Klein Taq as compared to the full-length Taq DNA polymerase. Klein Taq has a very low 'background' ability to extend a mismatched 3'-oligonucleotide end making it suitable for mutation analysis with mutation-specific oligonucleotides.

* The product is tested for the absence of endonucleases/ nickases and exonucleases.

*Unit definition: One unit of activity is defined as the amount of enzyme required to incorporate 10 nmoles of dNTP into acid-insoluble DNA fraction in 30 minutes at 72 C.

Info AppliChem GmbHAppliChem GmbH
AppliChem GmbH
Ottoweg 4
D-64291 Darmstadt
Germany
Tel: +49 (0)6151 / 9357-0
Fax: +49 (0)6151 / 9357-11

AppliChem Inc.
505 Highland Avenue
Cheshire, CT 06410 U.S.A.
Tel: (800) 620-7783
Fax: (800) 823-9903

Customer Service: +49 (0)6151 / 9357-0, 1 (800) 620-7783
Fax Number: +49 (0)6151 / 9357-11, 1 (800) 823-9903
Web Site: http://www.applichem.com/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. T4 DNA Polymerase from Roche Applied Science
2. T4 DNA Polymerase from Roche Applied Science
3. Poly A Polymerase from Invitrogen
4. iTaq DNA Polymerase, 250 U from Bio-Rad
5. iTaq DNA Polymerase, 5,000 U from Bio-Rad
6. Taq DNA Polymerase, 500 U (2 x 250 U) without dNTP from Bioneer, Inc.
7. T4 DNA Polymerase from Invitrogen
8. T4 DNA Polymerase from New England Biolabs
9. SP6 RNA Polymerase from Roche Applied Science
10. Taq DNA Polymerase (cloned) from GE Healthcare, formerly Amersham Biosciences
11. Mango-Taq DNA Polymerase from Bioline
Rabbit Anti-Human Retinoic Acid-Induced 3 (RAI3 / RAIG1) Polyclonal Antibody, Unconjugated from IMGENEX
Mouse Anti-Human GLP Monoclonal Antibody, Unconjugated, Clone 1B7B4 from ProMab Biotechnologies, Inc.
GIBCO Sf-900 Medium (1.3X) liquid from Invitrogen
Rabbit Anti-Human WDR77 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Biology Products:
(Date:11/3/2009)...or more than 25 years, all attempts at culturing p... been unsuccessfuluntil now. For the first time, n... beaded (nucleated) and non-beaded cultured pearls...tists from Florida Atlantic University,s Harbor Br...n two years of research and experimentation, Drs. ...
(Date:11/3/2009)...lished in a recent issue of HortTechnology , scie... effects of covering orchard floors with reflectiv...t distribution, orchard temperature, and profitabi...y and Solarmate films installed 5 weeks before com...es. The research showed that the use of both films...
(Date:11/3/2009)...uch as 28 percent less likely to become pregnant a...rch that earned a Michigan State University profes...Luke, a researcher in the MSU College of Human Med...eproductive Biology, focused on data of nearly 50,..., Luke,s findings, which also can be applied to ...
Breaking Biology News(10 mins):Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 3Reflective film can boost profits for apple growers 2MSU researcher: Obesity significantly cuts odds of successful pregnancy 2Veterans Give High Marks to VA Pharmacies 58710 1Veterans Give High Marks to VA Pharmacies 58710 2More than 5 000 Gallons of Bottled Water Now Available to Atlanta area Residents Coping with the Aftermath of Recent Flooding 58707 1More than 5 000 Gallons of Bottled Water Now Available to Atlanta area Residents Coping with the Aftermath of Recent Flooding 58707 2Neurocrine Biosciences Amends Corporate Headquarters Lease 14319 1
...cientists have discovered how the zebrafish (Danio... findings add to the growing list of tasks carried...the arrangement of everything from nerve cells to ...e research focused on a particular zebrafish mutan...e of the four stripes running down its side is mis...
...leCop(R) In Use by More Than 100 Ohio Police Depar...al,Inc. (OTC Bulletin Board: BKYI), a leader in fi...ublic safety solutions today announced the,award o...Department for the,deployment of BIO-key,s MobileC...ps in patrol vehicles will provide,Youngstown,s po...
... A ghostly, mutant ratfish caught off Whidbey Isla...no fish ever seen by both the curator of the Unive...llection and a fish and wildlife biologist with mo... "Ratfish usually hang out in places with soft, m...ery sciences doctoral student who found the albino...
Other Biology News:Study shows how the zebrafish gets his stripe 2Youngstown, Ohio Police Award Mobile Data Contract to BIO-key(R) International 2Youngstown, Ohio Police Award Mobile Data Contract to BIO-key(R) International 3Rare albino ratfish has eerie, silvery sheen 2Rare albino ratfish has eerie, silvery sheen 3
(Date:11/6/2009)...Nov. 6 Helix BioPharma C...announced that John Docherty, president and chief ... Ford,s 6th annual Investor Summit on November 10,...City. Mr. Docherty will provide an overview of th...-DOS47 and Topical Interferon Alpha-2b. The slide...
(Date:11/6/2009)..., Nov. 6 ,, 3Q09 C...f Qutenza(TM) E.U. Marketing Authorization to Aste...s in commercial readiness activities Expanded man... Marketing; and Director, Commercial Operations A...and Audit Committee chairman , Upcoming 200...
(Date:11/6/2009)...Nov. 6 Intarcia Therapeutics, Inc.... (DUROS® continuous delivery of exenatide) pr...Ninth Annual Diabetes Technology Meeting in San Fr...cgi-bin/prnh/20050301/SFTU126LOGO ) ,, Contin...50 Lowers Plasma Glucose, HbA1c and Reduces Weight...
(Date:11/5/2009)..., Nov. 5 GenVec, Inc. (N...ts for the third quarter ended September 30, 2009.... per share) for the three months ended September 3....08 per share) in the comparable quarter of 2008. ...ec,s net loss was $14.1 million ($0.15 per share),...
Breaking Biology Technology:Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6